iSpecimen Inc. (NASDAQ:ISPC) Sees Significant Growth in Short Interest

iSpecimen Inc. (NASDAQ:ISPCGet Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 169,200 shares, a growth of 138.6% from the April 15th total of 70,900 shares. Currently, 3.2% of the shares of the stock are short sold. Based on an average trading volume of 934,200 shares, the short-interest ratio is currently 0.2 days.

iSpecimen Stock Performance

Shares of NASDAQ ISPC opened at $0.24 on Monday. The firm’s fifty day moving average is $0.29 and its two-hundred day moving average is $0.44. iSpecimen has a 52-week low of $0.20 and a 52-week high of $1.88. The company has a market cap of $2.39 million, a P/E ratio of -0.19 and a beta of 1.48.

iSpecimen (NASDAQ:ISPCGet Free Report) last announced its quarterly earnings results on Wednesday, March 13th. The company reported ($0.34) EPS for the quarter. iSpecimen had a negative net margin of 124.84% and a negative return on equity of 105.25%. The firm had revenue of $2.58 million for the quarter.

iSpecimen Company Profile

(Get Free Report)

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.

Featured Articles

Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.